(CSEMAS) iShares VII - iShares MSCI - Ratings and Ratios

Exchange: SW • Country: Switzerland • Currency: USD • Type: Etf • ISIN: IE00B5L8K969

Emerging Market Stocks

Description: CSEMAS iShares VII - iShares MSCI

The iShares MSCI EM Asia ETF USD Acc is an exchange-traded fund that tracks the Morningstar Asia ex-Japan TME NR USD Index, providing investors with exposure to a diversified portfolio of Asian emerging markets equities, excluding Japan. This ETF is listed on the Swiss market, making it accessible to European investors.

As an Asia ex-Japan Equity ETF, it focuses on capturing the growth potential of emerging markets in the region, which include countries such as China, India, and South Korea. The fund is managed by BlackRock, one of the worlds largest and most reputable asset managers, ensuring a high level of expertise and resources dedicated to its management.

Analyzing the ETFs recent performance and technical indicators, we observe a bullish trend. The current price is near its 52-week high, indicating strong market momentum. The short-term (SMA20) and long-term (SMA50, SMA200) moving averages suggest a positive trend, with the shorter-term average above the longer-term averages, signaling an uptrend. The Average True Range (ATR) indicates moderate volatility, which is expected in emerging markets.

Combining the technical analysis with fundamental data, we note that the fund has a substantial Assets Under Management (AUM) of approximately $3.3 billion USD, indicating a reasonable level of liquidity and investor interest. Given the current trend and the fundamental strength of the underlying index, we forecast that the ETF will continue its upward trajectory in the short to medium term, potentially reaching new highs. However, investors should be aware of the inherent risks associated with emerging markets, including currency fluctuations, political instability, and economic volatility.

Based on the technical and fundamental analysis, our forecast suggests that the iShares MSCI EM Asia ETF USD Acc could potentially increase by 5-7% in the next quarter, driven by the ongoing growth in Asian emerging markets and the overall bullish trend in the ETFs price. Investors should monitor the ETFs performance and adjust their strategies according to their risk tolerance and investment goals.

Additional Sources for CSEMAS ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CSEMAS ETF Overview

Market Cap in USD 3,300m
Category Asia ex-Japan Equity
TER 0.20%
IPO / Inception 2010-08-06

CSEMAS ETF Ratings

Growth Rating 12.7
Fundamental -
Dividend Rating 2.19
Rel. Strength 1.13
Analysts -
Fair Price Momentum 200.69 USD
Fair Price DCF -

CSEMAS Dividends

Currently no dividends paid

CSEMAS Growth Ratios

Growth Correlation 3m 96%
Growth Correlation 12m 50.4%
Growth Correlation 5y -21.6%
CAGR 5y 5.38%
CAGR/Max DD 5y 0.12
Sharpe Ratio 12m -0.13
Alpha 2.21
Beta 0.616
Volatility 16.23%
Current Volume 2.7k
Average Volume 20d 1.6k
Stop Loss 200.9 (-3%)
What is the price of CSEMAS shares?
As of July 16, 2025, the stock is trading at USD 207.10 with a total of 2,678 shares traded.
Over the past week, the price has changed by +1.43%, over one month by +3.90%, over three months by +18.55% and over the past year by +14.08%.
Is iShares VII - iShares MSCI a good stock to buy?
Neither. Based on ValueRay´s Analyses, iShares VII - iShares MSCI is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 12.74 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CSEMAS is around 200.69 USD . This means that CSEMAS is currently overvalued and has a potential downside of -3.1%.
Is CSEMAS a buy, sell or hold?
iShares VII - iShares MSCI has no consensus analysts rating.
What are the forecasts for CSEMAS share price target?
According to our own proprietary Forecast Model, CSEMAS iShares VII - iShares MSCI will be worth about 225.6 in July 2026. The stock is currently trading at 207.10. This means that the stock has a potential upside of +8.92%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 225.6 8.9%